IL2 and neoplasm: LILRB4 blockade restored IL-2 production in HDVax-induced cells (Fig. 4f,g) and enhanced their expression of IFNγ/TNF and CD40L in both T3 and F244 tumour models (Extended Data Fig. 6g,j).